Limited-Time October Offer: Try 7 Days for Free

Regeneron (REGN) Stock Price

$557.8 0.4%

Sign up
to add to portfolio

AI Score

  • Alternative

    6

  • Fundamental

    6

  • Technical

    4

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Regeneron, AI stock picks, stock alerts and much more.

Sign up

REGN AI Stock Analysis

AI stock analysis for REGN is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron (REGN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Regeneron (REGN) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron (REGN), currently trading at $557.8, will... Sign up to access price prediction.

About REGN

LSE

  • Regeneron Pharmaceuticals, Inc.

  • Symbol

    REGN

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    58.1B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $19.3
0.9%
7
INO Inovio Pharmaceuticals
INO		 $2.42
0.6%
2
MRNA Moderna
MRNA		 $24.22
1.6%
4
AVXL Anavex Life Sciences
AVXL		 $8.64
1.7%
5
BBIO BridgeBio Pharma
BBIO		 $49.57
1.2%
6

News

Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
September 26, 2025. globenewswire.com
Regeneron: Looking For Green Shoots Of Growth On Top Of Heartwood Franchises

Regeneron: Looking For Green Shoots Of Growth On Top Of Heartwood Franchises
September 23, 2025. seekingalpha.com
Regeneron says blood cancer therapy shows 100% response rate in precancerous disorder study

Regeneron says blood cancer therapy shows 100% response rate in precancerous disorder study
September 19, 2025. reuters.com
Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J?

Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J?
September 19, 2025. investors.com

REGN Alternative Data

Web Traffic

Regeneron receives an estimated 345436 monthly visitors to regeneron.com.

  • Web Traffic

    345436

  • Change from Previous Month

    7.4%

Twitter Followers

Regeneron has 33,439 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.

  • Twitter Followers

    33439

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.4%

Facebook Engagement

Regeneron has engaged 886 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    886

  • Daily Change

    12.5%

  • 1 Month Change

    59.1%

  • 3 Month Change

    6.5%

Instagram Followers

Regeneron has 16,840 Instagram Followers on its main Instagram account, up by 0.4% over the last month.

  • Instagram Followers

    16840

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    2.2%

LinkedIn Followers

581,428 are following Regeneron on LinkedIn, up by 0.7% over the last month.

  • LinkedIn Followers

    581428

  • Daily Change

    0.1%

  • 1 Month Change

    0.7%

  • 3 Month Change

    3.7%

Job Postings

Regeneron currenly has an estimated 294 open job postings, up by 1% over the last month.

  • Job Postings

    294

  • Daily Change

    4.6%

  • 1 Month Change

    1%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Regeneron has 16,341 employees, down by -0.1% over the last month.

  • LinkedIn Employees

    16341

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.5%

Reddit Mentions

Regeneron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Regeneron is 68 out of 100 (bullish).

  • Business Outlook

    68

  • Change from Previous Month

    2.9%

REGN Financials

REGN Key Metrics

  • Total Revenue

    ¤0

  • Net Income

    ¤0

  • Earnings per Share

    ¤0

  • Free cash flow

    ¤0

  • EBITDA

    ¤0

  • EBITDA Ratio

  • Total Assets

    ¤0

REGN 2-year Revenue & Income
REGN 2-year Free Cash Flow

REGN Technicals

REGN SMA
REGN RSI

FAQ

What's the current price of Regeneron (REGN) Stock?
The price of an Regeneron (REGN) share is $557.8.

What's the market cap of Regeneron?
The current market cap of Regeneron is 58.1B.

What are some stocks similar to Regeneron (REGN) that investors often compare it to?
Regeneron (REGN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Regeneron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron's stock price to be around $569.2 in 2026. Starting from the current price of $557.8, this represents a 2% change in price, indicating a neutral outlook for the stock.

How to buy Regeneron (REGN) Stock?
Regeneron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.